STYLAGE® XL Bi-Soft w/Lidocaine

Where can I buy this product?

STYLAGE® XL Bi-Soft w/ Lidocaine may be available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license, for use only where legally permissible according to local and national regulations. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is STYLAGE® XL Bi-Soft w/ Lidocaine?

STYLAGE® XL Bi-Soft w/ Lidocaine is a sterile, viscoelastic, injectable gel implant composed of cross-linked hyaluronic acid (HA) of non-animal origin, manufactured by Vivacy Laboratories (France). As a primary volumizer in the Stylage line, it utilizes Vivacy’s proprietary IPN-Like Technology (InterPenetrated Network) and includes the antioxidant Mannitol. The “Bi-Soft” designation refers to Vivacy’s ergonomic syringe design intended to enhance injection comfort and precision for the practitioner.

This robust formulation contains a high concentration of cross-linked hyaluronic acid (26mg/g) and includes 0.3% lidocaine hydrochloride for patient comfort during deep injections. STYLAGE® XL is specifically designed for deep dermal, subcutaneous, or supraperiosteal injection to restore significant facial volume loss and sculpt facial contours, such as the cheeks, cheekbones, chin, and jawline.

Key Characteristics:

• Composition: Cross-linked HA (26 mg/g) + Mannitol + Lidocaine
• Technology: IPN-Like Technology
• Syringe Design: Bi-Soft ergonomic syringe
• Volume per Syringe: Typically 1ml (Pack Size: 2 x 1ml)
• Primary Function: Volumizer / Structural Contouring
• Storage: 2°C to 25°C (36°F and 77°F). Do not freeze. Protect from light.
• Claimed Longevity: Approximately 12 months or more (individual results vary).

Authenticity: Health Supplies Plus guarantees that all STYLAGE® products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners experienced in deep facial filler injections.

How does STYLAGE® XL Bi-Soft w/ Lidocaine work? (Based on Manufacturer Information)

STYLAGE® XL Bi-Soft w/ Lidocaine leverages the IPN-Like Technology to create a highly viscous and cohesive HA gel with significant lift capacity (high G’) and structural integrity. This makes it suitable for injection into deep tissue planes to provide substantial volume replacement and definition where needed most, counteracting age-related fat atrophy and skeletal changes.

When injected deeply (subcutaneously or onto bone), the gel provides immediate, robust structural support, effectively lifting tissues and sculpting facial contours like the cheeks, chin, and jawline. The inclusion of Mannitol as an antioxidant may help minimize immediate inflammatory responses and potentially enhance the longevity of the HA gel by scavenging free radicals. The manufacturer suggests IPN-Like technology contributes to the product’s durability.

Treatment results are immediately visible and intended to be long-lasting, often cited by the manufacturer as lasting 12 months or more, dependent on patient factors and treatment specifics. The integrated lidocaine aids patient comfort during these deeper, potentially more sensitive injections.

Indications for Use (Common Applications)

Based on its properties and common clinical use internationally, STYLAGE® XL Bi-Soft w/ Lidocaine is typically indicated for adults seeking significant facial volume restoration and sculpting:

• Restoration of lost facial volume (e.g., significant mid-face/cheek volumization).
• Augmentation and contouring of the cheeks, cheekbones, chin, and jawline.
• Correction of severe facial contour deficiencies requiring deep structural support.
• Facial remodeling requiring a high-volume, high-lift capacity filler.

This product necessitates deep injection techniques. Thorough anatomical knowledge, appropriate patient selection, and adherence to contraindications outlined in the product IFU are crucial. It is not indicated for treating ptosis (eyelid drooping) or fine lines.

Primary Benefits (Based on Manufacturer Claims)

• High-volume, high-viscosity formulation for significant facial sculpting and augmentation.
• Ideal for deep tissue/supraperiosteal placement for structural support (cheeks, chin, jawline).
• Utilizes IPN-Like Technology for optimized structure and integration.
• Contains Mannitol antioxidant for potential added benefits.
• Provides immediate, substantial volumizing and contouring results.
• Results claimed to last 12+ months.
• Features ergonomic Bi-Soft syringe design for enhanced handling.
• Includes lidocaine for improved patient comfort during deep injections.

Side Effects and Safety Information

Practitioners must obtain and consult the complete product information provided by the manufacturer for comprehensive details on administration, contraindications (including avoidance of anticoagulants/anti-inflammatories prior to injection as mentioned in source), warnings, precautions, and potential adverse events before using this product. Discussing all potential risks and side effects with patients is essential. Advanced training in deep injection techniques and thorough anatomical knowledge are mandatory for safe use.

Common side effects expected with deep HA filler injections include temporary, injection-site related reactions:

• Swelling (can be more pronounced due to volume/depth)
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Palpable Lumps/Bumps (may be more noticeable initially due to product robustness)

Severe Adverse Events:
Injecting high-volume, high-viscosity fillers deeply carries significant risks. Practitioners must be prepared to manage serious complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to severe tissue necrosis, scarring, or (in rare cases involving facial arteries) blindness or stroke. Knowledge of deep facial anatomy is paramount.
• Severe allergic reactions or hypersensitivity to HA, lidocaine, or other components
• Inflammation, infection, or abscess formation (risk may be higher with deep placement/large volumes)
• Nerve damage or impingement (due to deep injection near critical nerves)
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation.